Stock Movers

iHeartPodcasts
  • 0.0 (0)
  • Business News
  • Updated daily

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

  1. 10 hr ago

    Trainline Dips, Smith & Nephew Falls, Straumann Drops

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Trainline shares fell as much as 17%, the most in five years, after the UK competition watchdog opened an investigation into whether the rail-booking platform breached consumer law through “drip pricing.”- Smith & Nephew shares drop to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook.- Straumann drops as much as 9.1%, the most in a year, after the Swiss dental implant maker said Christopher Norbye would replace Guillaume Daniellot as CEO. Analysts at Bernstein and JPMorgan said Daniellot was “well-liked,” with the news overshadowing the better-than-expected earnings for the first half-year. See omnystudio.com/listener for privacy information.

  2. 11 hr ago

    Carlsberg Dips, Frontline Rises, Smith & Nephew Drops

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Carlsberg volume growth was softer than expected in the first half, as subdued beer demand in Europe and Asia undermined a strong performance in soft drinks.- Shares in Frontline PLC which owns a fleet of large crude carriers are benefiting from elevated crude tanker rates due to uncertainty in the Strait of Hormuz. - Smith & Nephew shares drop as much as 3.7% to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook. See omnystudio.com/listener for privacy information.

  3. 22 hr ago

    Targa Resources Rises, Meta Drops on Lawsuit, Duolingo Gains

    On this episode of Stock Movers: - Targa Resources (TRGP) shares rose as much as 9.8% to a record high after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046. Targa also announced a new 70-mile expansion of its planned Bull Run natural gas pipeline network in the Permian Basin region. - Meta Platforms (META) is being sued by 29 states for allegedly deceiving the public by targeting children on Facebook and Instagram with technology designed to turn them into compulsive users and drive up advertising revenue. The states allege that Meta knowingly designed features that encouraged compulsive and prolonged use of its platforms by young people, while simultaneously misleading consumers about safety features on its platforms. - Duolingo (DUOL) shares are up after D.A. Davidson upgraded the language learning platform to buy from neutral citing a “turning point” in acceleration of daily active user metrics. See omnystudio.com/listener for privacy information.

  4. 23 hr ago

    Closing Bell: Amylyx Pharmaceuticals Climbs, Targa Rises, Klarna Plunges

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux- Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.”- Targa Resources (TRGP) shares rose 6.9% after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046.- Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations. See omnystudio.com/listener for privacy information.

  5. 1 day ago

    Klarna Plunges, Home Depot Gains, Duolingo Rises

    Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers:- Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations.- Home Depot (HD) results beat estimates in the latest quarter, a sign that spending on improvement projects is holding up despite high borrowing and housing costs. The company’s strategy, which includes expanding its business serving professional contractors and building out its e-commerce offerings, has helped to blunt the impact of a housing market weighed down by high home prices and interest rates. Home Depot experienced healthy demand across the US and product departments during the quarter, with portable power tools, live plants, and patio products being especially popular.- Duolingo (DUOL) shares are up after D.A. Davidson upgraded the language learning platform to buy from neutral citing a “turning point” in acceleration of daily active user metrics. See omnystudio.com/listener for privacy information.

  6. 1 day ago

    Amer Sports Rises, Amylyx Jumps, and Klarna Plunges as FY Guidance Misses

    On this episode of Stock Movers:- Amer Sports (AS) shares rise. The maker of Wilson tennis rackets and Salomon ski boots boosted its guidance for revenue growth and adjusted earnings per share for the full year.- Amylyx (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.”- Klarna (KLAR) shares fell around after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations. See omnystudio.com/listener for privacy information.

  7. 1 day ago

    Fabrinet Declines, Baidu ADRs Fall, Klarna Sinks as Guide Cut Overshadows 2Q Rev Beat

    On this episode of Stock Movers:- Fabrinet (FN) shares fell. The process engineering and manufacturing services firm’s Datacom sales disappointed investors. The company also reported fourth-quarter results that beat expectations. - Baidu (BIDU) ADRs fall. The Chinese search-engine operator reported its fifth quarter of free cash outflow in the past six, thanks to soaring capital expenditures. It also reported AI-powered revenue that was weaker than analysts expected. - Klarna (KLAR) shares sink. The payments company slashed its full year revenue and gross merchandise value guidance, missing expectations. Active consumers for the second quarter also missed expectations. KBW said the key issue is the weaker second half outlook. See omnystudio.com/listener for privacy information.

  8. 1 day ago

    Klarna Plunges, Amylyx Pharma Soars, Bath & Body Works Rallies

    Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Shares of Klarna (KLAR) plunged in premarket trading after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. The company cited foreign exchange pressures and volumes in Germany, even as it reported a profit beat for the second straight quarter. The payments firm said in a statement that it expects between $4.08 billion and $4.16 billion of revenue this year, down from about $4.3 billion previously. Klarna said it had taken a “more measured view” of activity in Germany, its largest market by volumes. Active consumers for the second quarter also missed expectations.  - Shares of Amylyx Pharmaceuticals (AMLX) extended its rally in the early session to as much as 54%, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience low blood sugar levels following bariatric surgery. Amylyx plans to submit a new drug application to the US Food & Drug Adminstration by end of 2026, targeting a potential commercial launch in 2027. - Shares of Bath & Body Works (BBWI) surged ahead of the opening bell after Citi raised its recommendation on the stock to buy from neutral. Analyst Paul Lejuez cited a favorable risk/reward outlook in his note. The company is slated to release earnings next week. See omnystudio.com/listener for privacy information.

See All (2k)

Hosts & Guests

About

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Information

  • Creator
    iHeartPodcasts
  • Years Active
    2025 - 2026
  • Episodes
    2k
  • Rating
    Clean
  • Copyright
    2026 iHeartMedia, Inc. © Any use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from iHeartMedia
  • Show Website
    Stock Movers